drugset / Trial / NCT01035333
A Pilot Study of the Efficacy of Alli in the Management of Pre-operative Weight Loss Required for Bariatric Surgery.
Phase 4
Completed
19 enrolled
Albany College of Pharmacy and Health Sciences
Albany Medical College · collab
NaSingle-groupOpen-labelTreatment
Summary
The primary goal of the study is to determine if orlistat 60mg (Alli) is effective in helping patients achieve a required 10% weight loss goal prior to bariatric surgery. The medication will be added to the usual standard of care which includes education regarding diet and exercise and monthly meetings with a registered dietician.
Timeline
- Start
- 2009-11
- Primary completion
- 2011-04
- Completion
- 2011-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Orlistat | Small molecule | 60 mg | Oral |